Jayson Bedford
Stock Analyst at Raymond James
(3.84)
# 692
Out of 5,093 analysts
323
Total ratings
54.58%
Success rate
7.53%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $30.61 | -11.79% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $558.13 | +8.04% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $21.22 | -10.46% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $121.25 | +20.41% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $199.96 | +4.52% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $92.27 | +22.47% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $142.41 | +26.40% | 21 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $83.38 | +22.33% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $66.33 | +53.78% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $92.53 | +34.01% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $294.20 | +22.37% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $204 → $185 | $138.62 | +33.46% | 7 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $188.82 | +42.99% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $13.16 | -24.01% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $131.25 | +106.48% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $17.85 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $20.44 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $83.28 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $18.16 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $99.62 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $7.02 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $74.89 | +14.84% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.81 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $13.19 | - | 3 | Jan 2, 2018 |
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $30.61
Upside: -11.79%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $558.13
Upside: +8.04%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $21.22
Upside: -10.46%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $121.25
Upside: +20.41%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $199.96
Upside: +4.52%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $92.27
Upside: +22.47%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $142.41
Upside: +26.40%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $83.38
Upside: +22.33%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $66.33
Upside: +53.78%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $92.53
Upside: +34.01%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $294.20
Upside: +22.37%
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $138.62
Upside: +33.46%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $188.82
Upside: +42.99%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $13.16
Upside: -24.01%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $131.25
Upside: +106.48%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $17.85
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $20.44
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $83.28
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $18.16
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $99.62
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $7.02
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $74.89
Upside: +14.84%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $0.81
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $13.19
Upside: -